Heron Therapeutics
HRTX
HRTX
182 hedge funds and large institutions have $1.34B invested in Heron Therapeutics in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $1.08M
4% less funds holding
Funds holding: 190 → 182 (-8)
28% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 29
Holders
182
Holding in Top 10
4
Calls
$1.01M
Puts
$1.08M
Top Buyers
| 1 | +$29.7M | |
| 2 | +$16.3M | |
| 3 | +$8.44M | |
| 4 |
O
OrbiMed
New York
|
+$7.88M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.24M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$11.7M | |
| 3 | -$7.28M | |
| 4 |
Holocene Advisors
New York
|
-$5.9M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$5.33M |